콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

Eli Lilly Scores FDA Win for Pancreatic Cancer Drug. How It’s Moving Beyond GLP-1s.

요약

The company’s experimental cancer treatment, olomorasib, receives orphan drug designation from the Food and Drug Administration.